Cationic nanoparticle-mediated activation of natural killer cells for effective cancer immunotherapy KS Kim, JH Han, SH Choi, HY Jung, JD Park, HJ An, SE Kim, DH Kim, ... ACS Applied Materials & Interfaces 12 (51), 56731-56740, 2020 | 58 | 2020 |
Functional link between miR-200a and ELK3 regulates the metastatic nature of breast cancer HK Kim, JD Park, SH Choi, DJ Shin, S Hwang, HY Jung, KS Park Cancers 12 (5), 1225, 2020 | 26 | 2020 |
3D-printed NIR-responsive bullets as multifunctional nanodrug platforms for image-guided local chemo-photothermal therapy G Han, H Lee, JM Kang, JH Park, E Lee, ES Lee, S Park, Y Na, MH Kang, ... Chemical Engineering Journal 477, 147083, 2023 | 11 | 2023 |
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics JD Park, KS Kim, SH Choi, GH Jo, JH Choi, SW Park, ES Ko, M Lee, ... Journal for Immunotherapy of Cancer 10 (7), 2022 | 11 | 2022 |
Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy SH Choi, HJ Kim, JD Park, ES Ko, M Lee, DK Lee, JH Choi, HJ Jang, ... Journal for ImmunoTherapy of Cancer 10 (8), 2022 | 10 | 2022 |
Enhancing CAR‐NK Cells Against Solid Tumors Through Chemical and Genetic Fortification with DOTAP‐Functionalized Lipid Nanoparticles HE Shin, JH Han, JD Park, M Park, J Han, MH Kang, JS Lee, CG Park, ... Advanced Functional Materials, 2315721, 2024 | 9 | 2024 |
The ELK3-DRP1 axis determines the chemosensitivity of triple-negative breast cancer cells to CDDP by regulating mitochondrial dynamics JD Park, HJ Jang, SH Choi, GH Jo, JH Choi, S Hwang, W Park, KS Park Cell death discovery 9 (1), 237, 2023 | 5 | 2023 |
ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer HY Jung, DK Lee, M Lee, SH Choi, JD Park, ES Ko, J Lee, KS Park, ... Oncoimmunology 12 (1), 2190671, 2023 | 2 | 2023 |
ELK3-ID4 axis governs the metastatic features of triple negative breast cancer JH Choi, JD Park, SH Choi, ES Ko, HJ Jang, KS Park Oncology Research 32 (1), 127, 2023 | 2 | 2023 |